Company press releases

Displaying 101 - 150 of 184 results
Released Company Title Industry Topic
29 Nov 2022
15:15 CET 		BIOCARTIS Press release Biocartis Group NV: Biocartis Announces Successful Rights Offering 20101025 Health Services Change in Capital
29 Nov 2022
15:15 CET 		BIOCARTIS Persbericht Biocartis Group NV: Biocartis kondigt succesvolle aandelenuitgifte met voorkeurrecht aan 20101025 Health Services Change in Capital
29 Nov 2022
10:30 CET 		BIOCARTIS Press release Biocartis Group NV: Biocartis Announces 55.91% of Offered Shares Subscribed at Closing of Rights Subscription Period for Holders of Preferential Rights, and Start of Sale of Scrips through Private Placement to Inst. Investors 20101025 Health Services Other financial transaction
29 Nov 2022
10:30 CET 		BIOCARTIS Persbericht Biocartis Group NV: Biocartis kondigt aan dat op 55,91% van de aangeboden aandelen is ingeschreven bij afsluiting van inschrijvingsperiode voor houders van voorkeursrechten, ... 20101025 Health Services Other financial transaction
28 Nov 2022
17:45 CET 		BIOCARTIS Press release Biocartis Group NV: Expected Mandatory Conversion Bondholder Notification 20101025 Health Services Other financial transaction
28 Nov 2022
17:45 CET 		BIOCARTIS Persbericht Biocartis Group NV: Kennisgeving aan de Obligatiehouders betreffende Verwachte Verplichte Conversie 20101025 Health Services Other financial transaction
16 Nov 2022
07:00 CET 		BIOCARTIS Press release Biocartis Group NV: Biocartis launches a rights offering (with extra-legal preferential rights for existing shareholders) of a maximum of 33,476,932 offered shares, amounting to a maximum of EUR 25,107,699.00 20101025 Health Services Change in Capital
16 Nov 2022
07:00 CET 		BIOCARTIS Persbericht Biocartis Group NV: Biocartis lanceert een aandelenuitgifte met voorkeurrecht (met extralegale voorkeurrechten voor bestaande aandeelhouders) van maximaal 33.476.932 aangeboden aandelen,ten bedrage van maximaal EUR 25.107.699,00 20101025 Health Services Change in Capital
14 Nov 2022
17:40 CET 		BIOCARTIS Press release Biocartis Group NV: Results of the Extraordinary Shareholders’ Meeting held on 14 November 2022 20101025 Health Services General meeting / Board Meeting
14 Nov 2022
17:40 CET 		BIOCARTIS Persbericht Biocartis Group NV: Resultaten van de Buitengewone Algemene Aandeelhoudersvergadering gehouden op 14 november 2022 20101025 Health Services General meeting / Board Meeting
08 Nov 2022
07:00 CET 		BIOCARTIS Persbericht Biocartis Group NV: Nieuwe Idylla™ EGFR studie toont reductie van tijd-tot-behandeling met 48% voor longkankerpatiënten 20101025 Health Services Commercial operations
08 Nov 2022
07:00 CET 		BIOCARTIS Press release Biocartis Group NV: New Idylla™ EGFR Study Shows Reduction of Time-to-Treatment by 48% for Lung Cancer Patients 20101025 Health Services Commercial operations
31 Oct 2022
17:40 CET 		BIOCARTIS Persbericht Biocartis Group NV: Biocartis kondigt publicatie van negen Idylla™ studies aan op aankomende AMP 2022 Annual Meeting 20101025 Health Services Commercial operations
31 Oct 2022
17:40 CET 		BIOCARTIS Press release Biocartis Group NV: Biocartis Announces Nine Idylla™ Studies to be Published at Upcoming AMP 2022 Annual Meeting 20101025 Health Services Commercial operations
31 Oct 2022
07:00 CET 		BIOCARTIS Persbericht Biocartis Group NV: Biocartis kondigt de voltooiing aan van het ruilaanbod op haar bestaande converteerbare obligaties, en de uitgifte van nieuwe converteerbare obligaties 20101025 Health Services Other subject
31 Oct 2022
07:00 CET 		BIOCARTIS Press release Biocartis Group NV: Biocartis Announces Completion of Exchange Offer for its Existing Convertible Bonds, and issuance of New Convertible Bonds 20101025 Health Services Other subject
28 Oct 2022
07:01 CEST 		BIOCARTIS Press release Biocartis Group NV: Biocartis Announces Conversion of a Portion of the Convertible Term Loan into New Shares and Discloses Outstanding Voting Securities 20101025 Health Services Change in Capital
28 Oct 2022
07:01 CEST 		BIOCARTIS Persbericht Biocartis Group NV: Biocartis kondigt conversie aan van een deel van de converteerbare termijnlening in Nieuwe Aandelen en maakt uitstaande stemrechtverlenende effecten openbaar 20101025 Health Services Change in Capital
28 Oct 2022
07:00 CEST 		BIOCARTIS Press release Biocartis Group NV: Invitation to the Extraordinary Shareholders’ Meeting 20101025 Health Services General meeting / Board Meeting
28 Oct 2022
07:00 CEST 		BIOCARTIS Persbericht Biocartis Group NV: Oproeping tot de Buitengewone Algemene Aandeelhoudersvergadering 20101025 Health Services General meeting / Board Meeting
27 Oct 2022
17:40 CEST 		BIOCARTIS Press release Biocartis Group NV: Results of the Extraordinary Shareholders’ Meeting held on 27 October 2022 20101025 Health Services General meeting / Board Meeting
27 Oct 2022
17:40 CEST 		BIOCARTIS Persbericht Biocartis Group NV: Resultaten van de Buitengewone Algemene Aandeelhoudersvergadering gehouden op 27 oktober 2022 20101025 Health Services General meeting / Board Meeting
21 Oct 2022
07:00 CEST 		BIOCARTIS Press release Biocartis Group NV: Biocartis Reports Results of Third Quarter of 2022 20101025 Health Services Commercial results
21 Oct 2022
07:00 CEST 		BIOCARTIS Persbericht Biocartis Group NV: Biocartis kondigt resultaten derde kwartaal 2022 aan 20101025 Health Services Commercial results
20 Oct 2022
07:00 CEST 		BIOCARTIS Press release Biocartis Group NV: Biocartis Announces First Drawdown of New Convertible Term Loans 20101025 Health Services Other subject
20 Oct 2022
07:00 CEST 		BIOCARTIS Persbericht Biocartis Group NV: Biocartis kondigt eerste opname van nieuwe converteerbare termijnlening aan 20101025 Health Services Other subject
11 Oct 2022
07:00 CEST 		BIOCARTIS Persbericht Biocartis Group NV: Biocartis kondigt succesvolle wijziging aan van haar bestaande converteerbare obligaties 20101025 Health Services Other financial transaction
11 Oct 2022
07:00 CEST 		BIOCARTIS Press release Biocartis Group NV: Biocartis Announces Successful Amendment of its Existing Convertible Bonds 20101025 Health Services Other financial transaction
10 Oct 2022
07:00 CEST 		BIOCARTIS Persbericht Biocartis Group NV: Biocartis initieert commercialisatie in Europa van HepatoPredict (CE-IVD) test voor leverkankerpatiënten 20101025 Health Services Commercial operations
10 Oct 2022
07:00 CEST 		BIOCARTIS Press news Biocartis Group NV: Biocartis Initiates Commercialization in Europe of HepatoPredict (CE-IVD) Test for Liver Cancer Patients 20101025 Health Services Commercial operations
27 Sep 2022
07:00 CEST 		BIOCARTIS Persbericht Biocartis Group NV: Oproeping tot de Buitengewone Algemene Aandeelhoudersvergadering 20101025 Health Services Meetings / events
27 Sep 2022
07:00 CEST 		BIOCARTIS Press release Biocartis Group NV: Invitation to the Extraordinary Shareholders’ Meeting 20101025 Health Services Meetings / events
26 Sep 2022
07:40 CEST 		BIOCARTIS Press release Biocartis Group NV: Biocartis Announces Launch of Amendment Process and Exchange Offer for its Existing Convertible Bonds 20101025 Health Services Other financial transaction
26 Sep 2022
07:40 CEST 		BIOCARTIS Persbericht Biocartis Group NV: Biocartis kondigt start aan van wijzigingsproces en ruilaanbod voor haar bestaande converteerbare obligaties 20101025 Health Services Other financial transaction
06 Sep 2022
17:40 CEST 		BIOCARTIS Press release Biocartis Group NV: DISCLOSURE OF OUTSTANDING VOTING SECURITIES 20101025 Health Services Change in Capital
06 Sep 2022
17:40 CEST 		BIOCARTIS Persbericht Biocartis Group NV: OPENBAARMAKING VAN UITSTAANDE STEMRECHTVERLENENDE EFFECTEN 20101025 Health Services Change in Capital
01 Sep 2022
07:02 CEST 		BIOCARTIS Press release Biocartis Group NV: BIOCARTIS ANNOUNCES H1 2022 RESULTS 20101025 Health Services Commercial results
01 Sep 2022
07:02 CEST 		BIOCARTIS Persbericht Biocartis Group NV: BIOCARTIS KONDIGT H1 2022 RESULTATEN AAN 20101025 Health Services Commercial results
01 Sep 2022
07:01 CEST 		BIOCARTIS Press release Biocartis Group NV: Biocartis Initiates Commercialization in Europe of SkylineDx’s Innovative Merlin™ Assay (CE-IVD) for Melanoma Patients 20101025 Health Services Commercial operations
01 Sep 2022
07:01 CEST 		BIOCARTIS Persbericht Biocartis Group NV: Biocartis start commercialisatie in Europa van SkylineDx’s innovatieve Merlin™ Assay (CE-IVD) voor melanoma patiënten 20101025 Health Services Commercial operations
01 Sep 2022
07:00 CEST 		BIOCARTIS Press release Biocartis Group NV: Biocartis Announces Entry into Comprehensive Recapitalization Arrangements to Strengthen Cash Position and Support Growth 20101025 Health Services Change in Capital
01 Sep 2022
07:00 CEST 		BIOCARTIS Persbericht Biocartis Group NV: Biocartis kondigt aan alomvattende herkapitalisatie maatregelen aan te gaan om haar kaspositie te versterken en groei te ondersteunen 20101025 Health Services Change in Capital
25 Aug 2022
07:00 CEST 		BIOCARTIS Persbericht Biocartis Group NV: BIOCARTIS KONDIGT 2022 HALFJAARRESULTATEN AAN OP 1 SEPTEMBER 2022 20101025 Health Services Corporate life
25 Aug 2022
07:00 CEST 		BIOCARTIS Press release Biocartis Group NV: BIOCARTIS ANNOUNCES 2022 HALF-YEAR RESULTS ON 1 SEPTEMBER 2022 20101025 Health Services Corporate life
24 Aug 2022
07:00 CEST 		BIOCARTIS Persbericht Biocartis Group NV: Biocartis krijgt ISO 27001-certificaat voor Information Security Management 20101025 Health Services Corporate life
24 Aug 2022
07:00 CEST 		BIOCARTIS Press release Biocartis Group NV: Biocartis Obtains ISO 27001 Certification for Information Security Management 20101025 Health Services Corporate life
22 Jun 2022
07:00 CEST 		BIOCARTIS Persbericht Biocartis Group NV: Biocartis kondigt nieuwe overeenkomst aan met AstraZeneca voor de ontwikkeling en marketing van een companion diagnostic test voor Tagrisso® 20101025 Health Services Commercial operations
22 Jun 2022
07:00 CEST 		BIOCARTIS Press release Biocartis Group NV: Biocartis Announces New Agreement with AstraZeneca for the Development and Marketing of a Companion Diagnostic Test for Tagrisso® 20101025 Health Services Commercial operations
20 Jun 2022
07:00 CEST 		BIOCARTIS Press release Biocartis Group NV: Biocartis Announces Launch of its Rapid CE-marked IVD Idylla™ GeneFusion Panel for Fast Treatment Decisions in Lung Cancer 20101025 Health Services Commercial operations
20 Jun 2022
07:00 CEST 		BIOCARTIS Persbericht Biocartis Group NV: Biocartis kondigt lancering aan van zijn snelle CE-gemarkeerde IVD Idylla™ GeneFusion Panel voor snelle behandelingsbeslissingen in longkanker 20101025 Health Services Commercial operations